US Stock MarketDetailed Quotes

HURA TuHURA Biosciences

Watchlist
  • 6.560
  • +1.510+29.90%
Close Nov 29 13:00 ET
  • 6.714
  • +0.154+2.35%
Post 17:01 ET
277.39MMarket Cap-5606P/E (TTM)

TuHURA Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
41.57%-1.89M
-18.60%-3.83M
-59.17%-11.95M
-74.58%-3.23M
-14.40%-7.51M
-1.85M
-6.56M
Net income from continuing operations
88.45%-2.16M
74.12%-4.84M
-212.96%-29.32M
-778.02%-18.71M
-33.51%-9.37M
---2.13M
---7.02M
Operating gains losses
----
---12.09K
----
----
27.36%-294.07K
----
---404.85K
Depreciation and amortization
-71.88%17K
-43.24%34.31K
-52.46%177.38K
-35.70%60.45K
-2.00%373.09K
--94.01K
--380.69K
Other non cash items
----
--17.38K
--5.12K
----
----
----
--629.29K
Change In working capital
115.93%152K
166.43%633.7K
-68.83%486.92K
-711.09%-953.95K
421.26%1.56M
--156.11K
---486.2K
-Change in prepaid assets
--156K
----
----
----
----
----
----
-Change in payables and accrued expense
99.67%-4K
156.86%691.88K
-81.73%337.75K
-984.63%-1.22M
493.01%1.85M
--137.55K
---470.34K
-Change in other current assets
----
-122.13%-58.19K
152.07%149.18K
1,316.83%262.88K
-3,455.35%-286.51K
--18.55K
--8.54K
-Change in other working capital
----
----
----
----
----
----
---24.4K
Cash from discontinued investing activities
Operating cash flow
41.57%-1.89M
-18.60%-3.83M
-59.17%-11.95M
-74.58%-3.23M
-14.40%-7.51M
---1.85M
---6.56M
Investing cash flow
Cash flow from continuing investing activities
0
-3,474.93%-1.3M
-1.2M
-1,006.01%-36.28K
0
-3.28K
Net PPE purchase and sale
----
----
-118.39%-79.22K
----
-1,006.01%-36.28K
----
---3.28K
Net business purchase and sale
----
--0
---1.22M
---1.2M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
--0
-3,474.93%-1.3M
---1.2M
-1,006.01%-36.28K
--0
---3.28K
Financing cash flow
Cash flow from continuing financing activities
0
4.63M
-83.63%2.66M
0
130.69%16.25M
-150K
7.04M
Net issuance payments of debt
----
--4.9M
867.14%2.69M
--0
-219.02%-350K
---150K
--294.07K
Net common stock issuance
----
----
---24.75K
----
--0
----
--5.6M
Net preferred stock issuance
----
----
--0
----
1,342.98%16.6M
----
--1.15M
Cash dividends paid
--0
----
----
----
----
----
----
Net other financing activities
----
---272.3K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--4.63M
-83.63%2.66M
--0
130.69%16.25M
---150K
--7.04M
Net cash flow
Beginning cash position
-65.56%4.91M
-74.29%3.67M
156.98%14.25M
156.98%14.25M
9.43%5.55M
--5.55M
--5.07M
Current changes in cash
57.39%-1.89M
117.97%796.46K
-221.60%-10.59M
-121.45%-4.43M
1,721.77%8.71M
---2M
--477.91K
End cash Position
-69.25%3.02M
-54.57%4.46M
-74.29%3.67M
177.06%9.82M
156.98%14.25M
--3.54M
--5.55M
Free cash flow
41.57%-1.89M
-18.60%-3.83M
-59.45%-12.03M
-74.58%-3.23M
-14.89%-7.54M
---1.85M
---6.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Sep 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 41.57%-1.89M-18.60%-3.83M-59.17%-11.95M-74.58%-3.23M-14.40%-7.51M-1.85M-6.56M
Net income from continuing operations 88.45%-2.16M74.12%-4.84M-212.96%-29.32M-778.02%-18.71M-33.51%-9.37M---2.13M---7.02M
Operating gains losses -------12.09K--------27.36%-294.07K-------404.85K
Depreciation and amortization -71.88%17K-43.24%34.31K-52.46%177.38K-35.70%60.45K-2.00%373.09K--94.01K--380.69K
Other non cash items ------17.38K--5.12K--------------629.29K
Change In working capital 115.93%152K166.43%633.7K-68.83%486.92K-711.09%-953.95K421.26%1.56M--156.11K---486.2K
-Change in prepaid assets --156K------------------------
-Change in payables and accrued expense 99.67%-4K156.86%691.88K-81.73%337.75K-984.63%-1.22M493.01%1.85M--137.55K---470.34K
-Change in other current assets -----122.13%-58.19K152.07%149.18K1,316.83%262.88K-3,455.35%-286.51K--18.55K--8.54K
-Change in other working capital ---------------------------24.4K
Cash from discontinued investing activities
Operating cash flow 41.57%-1.89M-18.60%-3.83M-59.17%-11.95M-74.58%-3.23M-14.40%-7.51M---1.85M---6.56M
Investing cash flow
Cash flow from continuing investing activities 0-3,474.93%-1.3M-1.2M-1,006.01%-36.28K0-3.28K
Net PPE purchase and sale ---------118.39%-79.22K-----1,006.01%-36.28K-------3.28K
Net business purchase and sale ------0---1.22M---1.2M--0--0----
Cash from discontinued investing activities
Investing cash flow ------0-3,474.93%-1.3M---1.2M-1,006.01%-36.28K--0---3.28K
Financing cash flow
Cash flow from continuing financing activities 04.63M-83.63%2.66M0130.69%16.25M-150K7.04M
Net issuance payments of debt ------4.9M867.14%2.69M--0-219.02%-350K---150K--294.07K
Net common stock issuance -----------24.75K------0------5.6M
Net preferred stock issuance ----------0----1,342.98%16.6M------1.15M
Cash dividends paid --0------------------------
Net other financing activities -------272.3K--------------------
Cash from discontinued financing activities
Financing cash flow --0--4.63M-83.63%2.66M--0130.69%16.25M---150K--7.04M
Net cash flow
Beginning cash position -65.56%4.91M-74.29%3.67M156.98%14.25M156.98%14.25M9.43%5.55M--5.55M--5.07M
Current changes in cash 57.39%-1.89M117.97%796.46K-221.60%-10.59M-121.45%-4.43M1,721.77%8.71M---2M--477.91K
End cash Position -69.25%3.02M-54.57%4.46M-74.29%3.67M177.06%9.82M156.98%14.25M--3.54M--5.55M
Free cash flow 41.57%-1.89M-18.60%-3.83M-59.45%-12.03M-74.58%-3.23M-14.89%-7.54M---1.85M---6.57M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.28%